US Patent Issued to Mallinckrodt Pharmaceuticals Ireland on March 25 for "Systems and methods for manufacturing and safety of an NO 2 -to-NO reactor cartridge used to deliver no for inhalation therapy to a patient" (Wisconsin Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,257,391, issued on March 25, was assigned to Mallinckrodt Pharmaceuticals Ireland Ltd. (Dublin).

"Systems and methods for manufacturing and safety of an NO 2 -to-NO reactor cartridge used to deliver no for inhalation therapy to a patient" was invented by Jaron M. Acker (Madison, Wis.) and Thomas Kohlmann (McFarland, Wis.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The principles and embodiments of the present invention relate to methods and systems for safely providing NO to a recipient for inhalation therapy. There are many potential safety issues that may arise from using a reactor cartridge that converts NO2 to NO, including exhaustion of consuma...